Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.
Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show
A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous
October 25, 2023